Skip to Content
Merck
  • Application of targeted enrichment to next-generation sequencing of retroviruses integrated into the host human genome.

Application of targeted enrichment to next-generation sequencing of retroviruses integrated into the host human genome.

Scientific reports (2016-06-21)
Paola Miyazato, Hiroo Katsuya, Asami Fukuda, Yoshikazu Uchiyama, Misaki Matsuo, Michiyo Tokunaga, Shinjiro Hino, Mitsuyoshi Nakao, Yorifumi Satou
ABSTRACT

The recent development and advancement of next-generation sequencing (NGS) technologies have enabled the characterization of the human genome at extremely high resolution. In the retrovirology field, NGS technologies have been applied to integration-site analysis and deep sequencing of viral genomes in combination with PCR amplification using virus-specific primers. However, virus-specific primers are not available for some epigenetic analyses, like chromatin immunoprecipitation sequencing (ChIP-seq) assays. Viral sequences are poorly detected without specific PCR amplification because proviral DNA is very scarce compared to human genomic DNA. Here, we have developed and evaluated the use of biotinylated DNA probes for the capture of viral genetic fragments from a library prepared for NGS. Our results demonstrated that viral sequence detection was hundreds or thousands of times more sensitive after enrichment, enabling us to reduce the economic burden that arises when attempting to analyze the epigenetic landscape of proviruses by NGS. In addition, the method is versatile enough to analyze proviruses that have mismatches compared to the DNA probes. Taken together, we propose that this approach is a powerful tool to clarify the mechanisms of transcriptional and epigenetic regulation of retroviral proviruses that have, until now, remained elusive.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-CTCF Antibody, serum, Upstate®